(3-{2-[(4-Fluorophenyl)sulfonyl]benzyl}-2-methyl-4-oxo-4,5,6,7-tetrahydro-1H-indol-1-yl)acetic acid

ID: ALA3775213

Chembl Id: CHEMBL3775213

PubChem CID: 127029907

Max Phase: Preclinical

Molecular Formula: C24H22FNO5S

Molecular Weight: 455.51

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1c(Cc2ccccc2S(=O)(=O)c2ccc(F)cc2)c2c(n1CC(=O)O)CCCC2=O

Standard InChI:  InChI=1S/C24H22FNO5S/c1-15-19(24-20(6-4-7-21(24)27)26(15)14-23(28)29)13-16-5-2-3-8-22(16)32(30,31)18-11-9-17(25)10-12-18/h2-3,5,8-12H,4,6-7,13-14H2,1H3,(H,28,29)

Standard InChI Key:  GTXMSWKDWDLLNC-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3775213

    ---

Associated Targets(Human)

PEX16 Tbio Peroxisomal membrane protein PEX16 (26 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGDR2 Tchem G protein-coupled receptor 44 (4688 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 455.51Molecular Weight (Monoisotopic): 455.1203AlogP: 3.96#Rotatable Bonds: 6
Polar Surface Area: 93.44Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 3.33CX Basic pKa: CX LogP: 4.22CX LogD: 0.80
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.57Np Likeness Score: -1.07

References

1. Buil MA, Calbet M, Castillo M, Castro J, Esteve C, Ferrer M, Forns P, González J, López S, Roberts RS, Sevilla S, Vidal B, Vidal L, Vilaseca P..  (2016)  Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of sulphone-based CRTh2 antagonists.,  113  [PMID:26922232] [10.1016/j.ejmech.2016.02.023]

Source